"We, the people of the world, have got to own this new technology, so that the profits and rewards come broadly to people, rather than go to a few billionaires."
Prof. Richard Freeman, Harvard economics professor
"We, here on the continent, haven’t had a change of heart. Our hearts are still open to you"
European Council President
"There is no alternative for us other than to fight back. This is the biggest challenge for my generation"
Greek university student
""The main thing is we got him back on board, he is safe. But I think it just showed everyone how hard it is to actually see the guy in the water, even on a sunny day, 18 knots and sunshine, you know you wouldn't want to be doing it in 20 knots in the dark. I don't think you would find him you know.""
Skipper, Team Hun Sung Hai/Scallywag
"These are really important social issues that affect all of us all over in our communities. And we can't just leave this up to governments to solve these problems"
"‘Aussie flu’ is actually a bit of a misnomer. It is a strain that we have seen in previous seasons in the UK, in fact we saw it circulating last season. Hospital admissions have increased due to a combination of influenza A and B and no strain is currently dominating."
Professor Paul Cosford
Medical Director, Public Health England
""Oh it's a huge part! It's really exciting singing this and it's super challenging, to act and to sing. So for me it's really special to do it, really.""
"The poles amplify all the phenomena we see everywhere else on the globe"
This week’s Business Planet comes from the German city of Bonn.
Britain’s competition watchdog has fined Pfizer a record 98 million euros for radically raising the cost of an epilepsy drug.
The film “La Fille de Brest” – the daughter of Brest – rolls out like an inquiry.
Under mounting pressure, pharmaceutical company Mylan says it will slash the costs of emergency EpiPens for some patients in the US.
Pfizer has outbid Sanofi to buy the US cancer drug company Medivation, thereby acquiring the prostate cancer treatment Xtandi.
Monsanto has rejected an offer worth $62 billion (55.6 billion euros) from Bayer trying to create the world's biggest agricultural supplier.
Germany's Bayer has offered to buy US seeds company Monsanto for $62 billion (55 billion euros) in cash trying to gain the top spot in the fast-consolidating farm supplies industry.
Drug companies are saying No to death row. The latest pharmaceuticals giant to restrict sales of drugs used in lethal injections to US prisons is
The US Treasury has tightened its rules to prevent companies moving abroad to avoid US taxes. The immediate effect has been for the number one
French drugmaker Sanofi has pledged its 2016 earnings will be stable despite declining sales of diabetes and cancer treatments.
A former pharmaceuticals chief, who hiked the price of a life-saving medicine by more than five thousand percent, has refused to testify in front of
Gavi, an alliance committed to saving lives through vaccination, has put up $5 million for future purchases of a vaccine from US drugmaker Merck Sharp & Dohme to help take it through late-stage clinic
A man left brain dead after a clinical trial in France has now died. He was one of dozens of volunteers at a private facility to have tested an
A patient has died after falling into a coma following a medical trial in Rennes, northwest France. Five other people were hospitalised following the
It appears karma may have caught up with US entrepreneur Martin Shkreli, who has been arrested on fraud charges. In 2015 he became the internet’s
A British pharmaceuticals giant has been forced to pull a bestselling product from the shelves in Australia after a court order. Judges ruled Reckitt
A potent mix of Viagra and Botox is on the cards: their makers have agreed the healthcare sector’s biggest ever takeover deal. The transaction to
It’s worth over seven billion dollars – a Californian biotech company that makes drugs aimed at treating cancer, heart disease and neurological
The Irish-based group Allergan is in talks with Pfizer over a possible merger that would unite the US makers of Botox and Viagra – and create the
With an outstanding 1.1. billion euro bill to the pharmaceutical industry, there are fears that Greece could run out of medicine within three